Related Experiment Video
Updated: Mar 17, 2026

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
Published on: October 2, 2018
Biosynthesis-driven structure-activity relationship study of premonensin-derivatives
A Ismail-Ali1, E K Fansa2, N Pryk1
1Fakultät für Chemie und Biochemie, Organische Chemie 1, Ruhr-Universität Bochum, Universitätsstr. 150, 44780 Bochum, Germany. frank.schulz@rub.de.
Modified biosynthesis rapidly generates novel polyketide compounds for drug discovery. These compounds target the oncogenic KRas pathway by interacting with PDE6δ, showing high affinity for potential cancer therapeutics.
Area of Science:
- Natural product chemistry
- Drug discovery
- Biotechnology
Background:
- Controlled derivatization of natural products is crucial for drug discovery.
- Rapid generation of compound libraries is needed for structure-activity relationship (SAR) studies.
- Interference with the oncogenic KRas pathway is a key cancer research area.
Purpose of the Study:
- To generate a library of reduced polyketides using modified biosynthesis.
- To investigate the interaction of these polyketides with the KRas-interacting protein PDE6δ.
- To identify novel compounds for targeting the oncogenic KRas pathway.
Main Methods:
- Modified biosynthesis for polyketide library generation.
- Polyketide derivatization via side chain alteration.
- Manipulation of polyketide synthase for redox pattern and backbone length variation.
- Structural and biophysical analyses of polyketide-PDE6δ interactions.
Main Results:
- A library of reduced polyketides was successfully generated.
- The structural and biophysical basis for polyketide interaction with PDE6δ was elucidated.
- Non-natural polyketides with low nanomolar affinity to PDE6δ were identified.
Conclusions:
- Modified biosynthesis is an effective strategy for generating diverse polyketide libraries.
- Identified polyketides demonstrate high affinity for PDE6δ, suggesting therapeutic potential.
- These findings contribute to the development of novel KRas pathway inhibitors for cancer treatment.
More Related Videos
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Local Anesthetics: Chemistry and Structure-Activity Relationship

